A study to understand the effect of Integrated Amrita Meditation (IAM) in people with Diabetes
Phase 1
Completed
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2019/04/018606
- Lead Sponsor
- Amrita Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
Type 2 diabetic subjects in the age-group of 30 -70 yrs with diabetes of 1-10 years duration and whose HbA1C level ranged between 7 – 10 % were recruited for the study. These patients had not previously undergone any specialized relaxation training and volunteered to participate in the study.
Exclusion Criteria
Patients diagnosed with advanced diabetic complications - ongoing treatment for retinopathy/ renal impairment/ symptomatic or unstable heart disease / uncontrolled BP were excluded from the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood glucose , insulin resistance, HbA1c, lipid level blood pressure, adrenaline, cortisol and perceived stress assessed through standardized questionnaire PSS (Perceived Stress Scale)Timepoint: Baseline, 3 months, 6 months
- Secondary Outcome Measures
Name Time Method Serum insulin, IgA, CRP, IL 6 and inhibitory neurotransmitter GABA (? – Aminobutyric Acid)Timepoint: Baseline, 3 months, 6 months